In the eleven months starting from April 2024 to February 2025, around 700 patients have been treated using the ESWL (Extracorporeal Shock Wave Lithotripsy) at Government Rajaji Hospital in Madurai.

J&J’s new pivotal study in coronary artery disease, dubbed FORWARD CAD, will test a cardiac-focused version of the Javelin as ...

Johnson & Johnson MedTech‘s  Medical announced today that it initiated a study evaluating its Javelin coronary IVL catheter.

The device is differentiated from other Shockwave products, and rival catheters from Abbott and Boston Scientific, because it ...

The TECTONIC Coronary Artery Disease (CAD) Intravascular Lithotripsy (IVL) clinical trial will enroll up to 335 people in 47 sites in the U.S. Coronary Artery Disease (CAD) is the most common ...